TRYPSIN IV

Neova Technologies Inc.

TRYPSIN IV is one of our low endotoxin preparations specifically tailored for use as a reagent for cell and tissue culture applications. TRYPSIN IV comprises both trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.21.1) enzymatic activities. Available low-endotoxin alternatives with reduced chymotrypsin activity include TRYPSIN II and TRYPSIN 1:250.

TRYPSIN IV is provided in powder format, and can be processed either in irradiated, or non-irradiated forms suitable for direct use in culture media. We also offer standardisation of our trypsin products to your desired target protease or trypsin activities, in the excipient suited to your particular application. Contact us using the form below to learn more.

Applications

As a low-endotoxin preparation, TRYPSIN IV is highly valued in vaccine development, cell dissociation, cell harvesting, and similar applications. TRYPSIN IV is used to digest cell-attachment proteins in a measured manner; aiding in separating cells from each other, their extracellular matrix, or from the surface to which they are attached without damaging the cells themselves. For these purposes our reliable, standardised products contribute to optimised yields, and improved reproducibility.

Specification

Activity in USP units/mg

Trypsin: ≥ 250 U/mg

Chymotrypsin: ≤ 75 U/mg

Endotoxin: ≤ 10 EU/mg

 

Trypsin Grades

Medical, Pharmaceutical, and Research


 

 

Application Suitability TRYPSIN VI TRYPSIN IV TRYPSIN II TRYPSIN I TRYPSIN 1:250 TRYPSIN SE
Pancreatin
Vaccine Production            
Cell and Tissue Culture            
Mass Spectroscopy            
Diabetes & Ophthalmic research            
USP / EP guideline conformance            
Reduce Oedema and Bruising            
Enteral Feeding            

 

Food Processing, Infant Formula & Dietary Supplements


 

 

Application Suitability TRYPSIN VI TRYPSIN IV TRYPSIN II TRYPSIN I TRYPSIN 1:250 TRYPSIN SE
Pancreatin
Whey Protein Hydrolysis            
Production of Infant Formula            
Production of Hypoallergenic Infant Formula            
Food Processing            
Meat and Seafood Tenderisation            
Enhancement of Food Digestibility            
Dietary Supplementation            
Functional Foods            

 

 

Neova Technologies Inc., part of Bioseutica® group, has been extracting pancreatic enzymes for over 25 years. As one of the largest global manufacturers of porcine-derived enzymes, we have the experience to tailor our preparations to the exacting specifications of our customers. Contact us using the form below to discuss your specific requirements.

No Warranty: The information contained herein is provided in good faith and, to the best of our knowledge, is true and correct. However, no warranty or guarantee is implied or inferred and the information may be subject to change without prior notice. Neova Technologies Inc.’s products are sold with the understanding that the purchaser will conduct tests to determine the suitability of these products for their particular use.

Related Products
Show in grid
On

More information

Address
Privacy